BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20085679)

  • 1. Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy.
    Leung DT; Henning PA; Wagner EC; Blasig A; Wald A; Sacks SL; Corey L; Money DM
    J Obstet Gynaecol Can; 2009 Dec; 31(12):1137-43. PubMed ID: 20085679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral acyclovir and recurrent genital herpes during late pregnancy.
    Haddad J; Langer B; Astruc D; Messer J; Lokiec F
    Obstet Gynecol; 1993 Jul; 82(1):102-4. PubMed ID: 8390630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis.
    Randolph AG; Hartshorn RM; Washington AE
    Obstet Gynecol; 1996 Oct; 88(4 Pt 1):603-10. PubMed ID: 8841227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir suppression to prevent recurrent genital herpes at delivery.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.
    Brocklehurst P; Kinghorn G; Carney O; Helsen K; Ross E; Ellis E; Shen R; Cowan F; Mindel A
    Br J Obstet Gynaecol; 1998 Mar; 105(3):275-80. PubMed ID: 9532986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
    Frenkel LM; Brown ZA; Bryson YJ; Corey L; Unadkat JD; Hensleigh PA; Arvin AM; Prober CG; Connor JD
    Am J Obstet Gynecol; 1991 Feb; 164(2):569-76. PubMed ID: 1847004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding.
    Braig S; Luton D; Sibony O; Edlinger C; Boissinot C; Blot P; Oury JF
    Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):55-8. PubMed ID: 11311761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.
    Scott LL; Sanchez PJ; Jackson GL; Zeray F; Wendel GD
    Obstet Gynecol; 1996 Jan; 87(1):69-73. PubMed ID: 8532270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
    Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of perinatal herpes: prophylactic antiviral therapy?
    Scott LL
    Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
    Hollier LM; Wendel GD
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertical transmission of genital herpes: prevention and treatment options.
    Jones CA
    Drugs; 2009; 69(4):421-34. PubMed ID: 19323586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
    Kimberlin DF; Weller S; Whitley RJ; Andrews WW; Hauth JC; Lakeman F; Miller G
    Am J Obstet Gynecol; 1998 Oct; 179(4):846-51. PubMed ID: 9790357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery.
    Watts DH; Brown ZA; Money D; Selke S; Huang ML; Sacks SL; Corey L
    Am J Obstet Gynecol; 2003 Mar; 188(3):836-43. PubMed ID: 12634667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir treatment of primary herpes in pregnancy complicated by second trimester preterm premature rupture of membranes with term delivery: case report.
    Dietrich YM; Napolitano PG
    Am J Perinatol; 2002 Jul; 19(5):235-8. PubMed ID: 12152140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
    Kimberlin DW; Baley J; ;
    Pediatrics; 2013 Feb; 131(2):e635-46. PubMed ID: 23359576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Sénat MV; Anselem O; Picone O; Renesme L; Sananès N; Vauloup-Fellous C; Sellier Y; Laplace JP; Sentilhes L
    Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):705-714. PubMed ID: 29132768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current recommendations for the treatment of genital herpes.
    Leung DT; Sacks SL
    Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.